POSTER: AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/MLL1 Rearrangements, NPM1 Mutation), DLBCL, MM, and CLL/SLL (NCT05153330)

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 23; p. S171
Main Authors Ravandi, Farhad, Lancet, Jeffrey, Amor, Adrian Alegre, Badar, Talha, Barrientos, Jacqueline, Bashey, Asad, Burgues, Juan Miguel Bergua, Curran, Emily, Janssen, Jeroen, Jeyakumar, Deepa, Kishtagari, Ashwin, Montesinos, Pau, Morillo, Daniel, Rosenberg, Aaron, Schiller, Gary, Ahmed, Uzma, Cacovean, Alex, Morris, Steve, Follit, Courtney, Mandap, Clarissa, Butler, Thomas, Carraway, Hetty
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2023
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)00513-X